Reaction Details Report a problem with these data
Target
Protein Nef
Ligand
BDBM288055
Substrate
n/a
Meas. Tech.
Measurement of Antiviral (HIV-1) Activity
Temperature
298.15±n/a K
EC50
6.90±n/a nM
Comments
extracted
Citation
 Miyazaki, S; Isoshima, H; Oshita, K; Kawashita, S; Nagahashi, N; Terashita, M Substituted spiropyrido[1,2-a]pyrazine derivative and medicinal use thereof as HIV integrase inhibitor US Patent  US10087178 Publication Date 10/2/2018 
Target
Name:
Protein Nef
Synonyms:
3ORF | F-protein | HIV-1 Nef | NEF_HV1BR | Negative factor | Protein Nef | nef
Type:
C-terminal core protein
Mol. Mass.:
23340.47
Organism:
Human immunodeficiency virus type 1 (isolate BRU/LAI group M subtype B)
Description:
P03406
Residue:
206
Sequence:
MGGKWSKSSVVGWPTVRERMRRAEPAADGVGAASRDLEKHGAITSSNTAATNAACAWLEAQEEEEVGFPVTPQVPLRPMTYKAAVDLSHFLKEKGGLEGLIHSQRRQDILDLWIYHTQGYFPDWQNYTPGPGVRYPLTFGWCYKLVPVEPDKVEEANKGENTSLLHPVSLHGMDDPEREVLEWRFDSRLAFHHVARELHPEYFKNC
  
Inhibitor
Name:
BDBM288055
Synonyms:
US10087178, Example S15 | trans-3-(benzyloxy)-N-(2,4- difluorobenzyl)-2'-ethyl-9'- hydroxy-1',8'-dioxo- 1',2',3',8'- tetrahydrospiro[cyclobutane- 1,4'-pyrido[1,2-a]pyrazine]- 7'-carboxamide hydrochloride
Type:
Small organic molecule
Emp. Form.:
C28H27F2N3O5
Mol. Mass.:
523.5279
SMILES:
CCN1C[C@@]2(C[C@@H](C2)OCc2ccccc2)n2cc(C(=O)NCc3ccc(F)cc3F)c(=O)c(O)c2C1=O |r,wU:4.4,6.8,(8,2.24,;6.67,3.01,;5.33,2.24,;5.33,.7,;4,-.07,;2.91,-1.15,;4,-2.24,;5.09,-1.15,;4,-3.78,;5.33,-4.55,;6.67,-3.78,;8,-4.55,;9.34,-3.78,;9.34,-2.24,;8,-1.47,;6.67,-2.24,;2.67,.7,;1.33,-.07,;,.7,;-1.33,-.07,;-1.33,-1.61,;-2.67,.7,;-4,-.07,;-5.33,.7,;-5.33,2.24,;-6.67,3.01,;-8,2.24,;-9.34,3.01,;-8,.7,;-6.67,-.07,;-6.67,-1.61,;,2.24,;-1.33,3.01,;1.33,3.01,;1.33,4.55,;2.67,2.24,;4,3.01,;4,4.55,)|
Structure:
Search PDB for entries with ligand similarity: